NZ181972A - N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions - Google Patents

N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions

Info

Publication number
NZ181972A
NZ181972A NZ181972A NZ18197276A NZ181972A NZ 181972 A NZ181972 A NZ 181972A NZ 181972 A NZ181972 A NZ 181972A NZ 18197276 A NZ18197276 A NZ 18197276A NZ 181972 A NZ181972 A NZ 181972A
Authority
NZ
New Zealand
Prior art keywords
piperidyl
aryl
pharmaceutical compositions
arylacetamide
derivatives
Prior art date
Application number
NZ181972A
Inventor
Fr H Hermans
S Sanczuk
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NZ181972A publication Critical patent/NZ181972A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ181972A 1975-09-23 1976-09-08 N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions NZ181972A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
NZ181972A true NZ181972A (en) 1978-07-28

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ181972A NZ181972A (en) 1975-09-23 1976-09-08 N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
EP2148872A1 (en) * 2007-04-23 2010-02-03 Janssen Pharmaceutica, N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
KR101506156B1 (en) 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN101663292A (en) 2007-04-23 2010-03-03 詹森药业有限公司 4-alkoxypyridazine derivatives as quick dissociated dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
EA019048B1 (en) 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Piperazin-1-yl-trifluoromethyl-substituted pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
IL50522A0 (en) 1976-11-30
DE2642856C2 (en) 1990-06-21
NL7610513A (en) 1977-03-25
DK150478C (en) 1987-10-05
IL50522A (en) 1979-09-30
CS222663B2 (en) 1983-07-29
ES451768A1 (en) 1978-05-01
PH12497A (en) 1979-04-05
GR58469B (en) 1977-10-14
LU75837A1 (en) 1977-05-04
AU1787876A (en) 1978-03-23
SE427839B (en) 1983-05-09
AT363935B (en) 1981-09-10
FR2325377A1 (en) 1977-04-22
ATA702976A (en) 1981-02-15
SE7610501L (en) 1977-03-24
IT1073893B (en) 1985-04-17
YU233676A (en) 1983-01-21
CH628623A5 (en) 1982-03-15
CA1068271A (en) 1979-12-18
AU510029B2 (en) 1980-06-05
PT65631B (en) 1978-07-05
PL192578A1 (en) 1979-02-26
NO147672C (en) 1983-05-25
FI61482C (en) 1982-08-10
JPS5239683A (en) 1977-03-28
IE43802B1 (en) 1981-06-03
NO763054L (en) 1977-03-24
NO147672B (en) 1983-02-14
JPS6016417B2 (en) 1985-04-25
FR2325377B1 (en) 1980-04-18
DK150478B (en) 1987-03-09
SU747424A3 (en) 1980-07-23
NL187267B (en) 1991-03-01
HU172964B (en) 1979-01-28
PT65631A (en) 1976-10-01
YU39973B (en) 1985-06-30
DE2642856A1 (en) 1977-03-24
IE43802L (en) 1977-03-23
FI61482B (en) 1982-04-30
NL187267C (en) 1991-08-01
BG27543A3 (en) 1979-11-12
PL117323B1 (en) 1981-07-31
DK427876A (en) 1977-03-24
RO70079A (en) 1982-10-26
FI762698A (en) 1977-03-24
GB1539473A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
NZ179835A (en) Aminoalkynoic acids,derivatives and pharmaceutical compositions
NZ182665A (en) Amine derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ181959A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ181009A (en) Heteroaryl derivatives and pharmaceutical compositions
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
KE3219A (en) Pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
NZ181088A (en) Cyclopropanol derivatives and pharmaceutical compositions